Chronic portal hypertension following inotuzumab ozogamicin in a low-risk patient: a case of overriding baseline risk and long-term management. - Wu J; Cao J; Gao L; Yang M; Shao J; Zhang Y; Xu X; Cai Y; Wei Y; Song X; Wan L (Annals of hematology, 2026)